**No Level 4 travel health notice is currently active.** The CDC’s latest update (June 11, 2026) explicitly states there are zero notices at Level 4—“Avoid All Travel”—which applies only when extreme health risks exist and no effective precautions are available. Recent notices remain at Level 1 (e.g., dengue across 16 countries in March 2026) or Level 2 (chikungunya advisories), reflecting localized or manageable transmission rather than uncontrolled outbreaks. Ongoing surveillance data show routine U.S. and international outbreaks (salmonella, listeria, Andes virus on a cruise) that do not meet the threshold for global Level 4 escalation. With six months remaining until year-end and no emerging pathogen or surge approaching pandemic-scale risk, trader consensus favors “No” at 75% implied probability. New CDC notices are published weekly, so any rapid deterioration in a high-impact pathogen would be the clearest catalyst for odds movement.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$71,851 Vol.
$71,851 Vol.
はい
$71,851 Vol.
$71,851 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
マーケット開始日: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...**No Level 4 travel health notice is currently active.** The CDC’s latest update (June 11, 2026) explicitly states there are zero notices at Level 4—“Avoid All Travel”—which applies only when extreme health risks exist and no effective precautions are available. Recent notices remain at Level 1 (e.g., dengue across 16 countries in March 2026) or Level 2 (chikungunya advisories), reflecting localized or manageable transmission rather than uncontrolled outbreaks. Ongoing surveillance data show routine U.S. and international outbreaks (salmonella, listeria, Andes virus on a cruise) that do not meet the threshold for global Level 4 escalation. With six months remaining until year-end and no emerging pathogen or surge approaching pandemic-scale risk, trader consensus favors “No” at 75% implied probability. New CDC notices are published weekly, so any rapid deterioration in a high-impact pathogen would be the clearest catalyst for odds movement.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問